CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 926363-926409 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/68a7101a90454172c91785d8c352f776a82df5d4","sourcedb":"CORD-19","sourceid":"68a7101a90454172c91785d8c352f776a82df5d4","text":"Pathogenic antibodies in neuromyelitis optica:","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T82870","span":{"begin":0,"end":46},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T82870","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T263","span":{"begin":0,"end":46},"obj":"Sentence"}],"attributes":[{"subj":"T263","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5806","span":{"begin":25,"end":45},"obj":"Disease"},{"id":"T24656","span":{"begin":25,"end":45},"obj":"Disease"}],"attributes":[{"id":"A5806","pred":"mondo_id","subj":"T5806","obj":"http://purl.obolibrary.org/obo/MONDO_0019100"},{"id":"A51207","pred":"mondo_id","subj":"T24656","obj":"http://purl.obolibrary.org/obo/MONDO_0019100"},{"subj":"T5806","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T24656","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93d5ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ece993"},{"id":"CORD-19-PD-MONDO","color":"#cf93ec"}]}]}}